Human medicines European public assessment report (EPAR): Akeega, niraparib,abiraterone acetate, Prostatic Neoplasms, Castration-Resistant, Date of authorisation: 19/04/2023, Status: Authorised
Human medicines European public assessment report (EPAR): Akeega, niraparib,abiraterone acetate, Prostatic Neoplasms, Castration-Resistant, Date of authorisation: 19/04/2023, Status: Authorised
door | jun 2, 2023 | EMEA